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Background: Anorexia nervosa commonly arises during adolescence and is associated with more than one medical
morbidity. Abnormalities in brain structure (defined as “pseudoatrophy”) are common in adolescents with anorexia
nervosa; however, their correlations with endocrinological profiles and clinical parameters are still unclear. In
particular, no study has described the impact of BMI (body mass index) variations (speed and magnitude of weight
loss) on cerebral trophism changes.
Methods: Eleven adolescents with anorexia nervosa and 8 healthy controls underwent cerebral MRI (magnetic
resonance imaging) examination to obtain global and partial volumes (gray matter, white matter and cerebrospinal
fluid) and clinical evaluation. The Mann-Whitney U test was used to compare partial volumes and clinical variables
between cases and controls. The Spearman non-parametric test was performed in order to explore correlations
between the variables studied.
Results: The patients diagnosed with AN showed significantly increased cerebrospinal fluid (CSF) volumes and
decreased total gray (GM) and white matter (WM) volumes. The degree of weight loss (deltaBMI) correlated
inversely with the GM volume; the increase of CSF compartment correlated directly with the rapidity of weight loss
(DeltaBMI/disease duration).
Conclusions: This study suggests a correlation between cerebral alterations in AN and the speed and magnitude of
weight loss, and outlines its importance for the therapeutic treatment.
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Anorexia nervosa (AN) is a psychiatric illness that
commonly arises during adolescence. Among all the
psychiatric disorders anorexia has the highest mortality
rate and it is associated with severe medical morbidity
[1]. Regard to complications, heart abnormalities [2],
osteopenia [3], endocrine alterations and brain abnor-
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reproduction in any medium, provided the orThe typical hypothalamic amenorrhea is associated with
low serum levels of gonadotropins and sexual hormones.
Plasmatic levels of leptin, a peptide produced by fat store
and involved in appetite-regulating mechanisms, are also
reduced. GH (growth hormone) levels are often increased
accompanied by low levels of IGF-1 (insulin-like growth
factor) which suggests an acquired peripheral resistance
to GH. An hypercortisolemia is common to almost all
women with AN, but not associated to the typical
Cushingoid features and often not suppressible after
dexamethasone administration. Abnormalities of the thy-
roid axis are also relevant and characterized by low levels
of T3 (triiodothyronine), whereas T4 (thyroxine) and TSHLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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reduced [4,5].
Previous neuroimaging studies on AN showed global gray
(GM) and white matter (WM) reduction and an increase in
cerebrospinal fluid volumes (CSF) [6,7], while other authors
didn’t confirm GM [8,9] or WM decrease [10].
In literature, associations between brain alterations and
hormonal profile changes as hypercortisolemia [6,11,12]
and low levels of T3 [12-14] are described.
Weight restoration tends to improve brain abnormal-
ities in AN, but it is still not clear whether reversibility is
complete [6,8,10,15,16]. Etiopatogenetic mechanism of
cerebral alterations are not still completely explained.
First hypothesis that volume reductions are related to
neuron death has not been confirmed either by neuro-
biochemical [17], histological studies [18] or by improve-
ment of brain alterations with weight restoration [10].
The current hypothesis, summarized in Swayze’s study
[8], include: i) decreased serum proteins resulting in
decreased colloidal osmotic pressure and a shift of fluid
from the intravascular space into the subarachnoid
spaces [19]; ii) partial regeneration of damaged neurons
and their axons with possible regeneration of myelin
[20]; iii) loss of lean body tissue mass [21]; iv) increased
urine and serum cortisol levels [22]; v) decreased protein
synthesis resulting in loss of dendritic spines, a reduc-
tion in the number of synaptic junctions, and delayed
synaptogenesis [7].
In literature associations between brain volumes and
BMI in AN are known [6], anyway no study explored
the impact of speed and magnitude of weight loss on
cerebral trophic changes in adolescents with anorexia
nervosa. The purpose of our study is to examine this
correlation and its implications in the clinical treatment
of these young patients.
Methods
Eleven girls, aged 11–17, who fulfilled the DSM-IV-TR
diagnostic criteria for AN were enrolled. They were all
new patients of the Eating Disorders Unit of the Depart-
ment of Child and Adolescent Neuropsychiatry, at the
S. Gerardo Hospital in Monza, University of Milano
Bicocca (Milan, Italy) from August 2008 to January 2010.
Clinical variables such as age, body-mass-index (BMI), age
of AN onset, deltaBMI (index of body weight loss which
expresses the variation of the BMI between the onset of
the disorder and the evaluation), deltaBMI/disease du-
ration (rapidity of BMI variation), the presence of primary/
secondary amenorrhea were evaluated by means of a cli-
nical interview. No patient was taking any medication. The
Hollingshead 4-factor index was carried out as a measure
of the socio-economical status (SES). A normal academic
performance was reported for all the girls enrolled.
Patients did not have any concomitant medical diseases(except for one girl affected by celiac disease) or psychi-
atric comorbidity and no prenatal/perinatal/postnatal ce-
rebral suffering was reported.
Eight age-matched girls without psychiatric disorders
were also enrolled as controls.
Each subject underwent a high-resolution T1-weighted
volume MRI scan Acquisition consists of a set of adjacent
axial images with a slice thickness of 1 mm and pixel size
0.94 _ 0.94 mm, using spoiled gradient echo sequence
(TR = 25; TE = 4.6 kHz; FOV = 240 cm; matrix 256 _ 256).
All MRI data was acquired on the same scanner (1.5 T
Achieva Philips) using the same parameters according to
strictly standardized procedures. Total cerebral and intra-
cranial volumes (gray matter, white matter, cerebrospinal
fluid) were calculated using the FAST and BET extraction
tools from the FSL package (http://www.fmrib.ox.ac.uk/fsl/).
For each MRI scan a binary mask of cerebral volume was
obtained with the BET extraction tool (threshold fixed
was 0.5) and then manually outlined.
Parents and participants were told the purpose of the
study and a written informed consent to participate was
obtained. The research was reviewed and approved by
the Institutional Review board.
Statistics
All continuous variables were expressed as mean ± SD
(standard deviation). The Mann-Whitney U test was
used to compare partial volumes (GM, WM, CSF), and
clinical variables between cases and controls. In the
group of adolescents with anorexia nervosa, the Spear-
man non-parametric test was performed in order to ex-
plore correlations between the variables studied. The
level of significance was set at p < 0.05. Statistical ana-
lysis was performed using the SPSS 19 package.
Results
The socio-demographic features and BMI of participants
with AN and controls are described in Table 1. Subjects
with AN presented a mean deltaBMI of 3.9 (S. D. 2.73),
a mean time of disease duration of 14.45 (S. D. 10.92)
months and a mean deltaBMI/disease duration of 0.70
(S.D. 0.80). Three girls with AN presented primary
amenorrhea, eight girls secondary amenorrhea. Nine
girls suffered from restrictive and two suffered from pur-
ging type of AN.
Differences in WM, GM and CSF volumes, when com-
paring the two groups (Table 2) were found: participants
with AN showed reduced GM (586215 mm3, SD = 60592
in the AN group vs 689829 mm3, SD = 64033 in the control
group; p < 0.005) and WM volumes (465369mm3, SD =
44689 in the AN group vs 521839mm3, SD = 23645 in the
control group; p < 0.02), and higher CSF volumes than
controls (315480mm3, SD = 55098 in the AN group vs
221033 mm3, SD = 24736 in the control group; p < 0.002).
Table 1 Socio-demographic and clinical features of




Mean (S.D.) Mean (S.D.)
n = 11 n = 8
Age 13.63 (2.77) 13.25 (2.43) -
0.17
0.87
Hollingshed index 2.73 (1.27) 2.50 (1.69) -
0.55
0.58
BMI k/m2 12.18 (0.87) 19.87 (1.45) - 3.7 <0.001
DeltaBMI 3.9 (2.73) - -
Disease Duration
(months)
14.45 (10.92) - - -
DeltaBMI/Disease
duration
0.70 (0.80) - - -
a Mann –Whitney U-test.
AN = anorexia nervosa.
S.D. = standard deviation.
BMI = body mass index.
DeltaBMI = (Delta body mass index) index of body weight loss which expresses
the variation of the BMI between the onset of the disorder and the evaluation.
Table 3 Correlations between Volumetric and Clinical




DeltaBMI Gray matter −0.724 <0.02




a Spearman non-parametric test.
DeltaBMI = index of body weight loss which expresses the variation of the BMI
between the onset of the disorder and the evaluation.
DeltaBMI/disease duration (rapidity of BMI variation).
CSF = cerebrospinal fluid.
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tion of GM volume, which means that girls with AN
with the greatest weight loss between the onset of the
disease and the time at diagnosis had the greatest reduc-
tion of GM volume. Delta BMI also directly correlated
with the enlargement of CSF volume. Moreover, a direct
correlation was also observed between the CSF compart-
ment volume and the fraction DeltaBMI/disease du-
ration (Table 3).
Discussion
To our knowledge, this is the first study conducted on
a sample of young adolescents with AN in which
correlations between cerebral volumes and speed and
magnitude of weight loss are explored. A negative cor-
relation between deltaBMI and the fraction of gray mat-
ter volume and a positive correlation between deltaBMI
and the enlargement of CSF volume were observed. To
the contrary, no correlations between cerebral volume
parameters and BMI value were found [10], which mayTable 2 Comparison of volumetric measures between
participants with AN and controls
AN group Control group pa
Mean (S.D.) Mean (S.D.)
Gray matter mm3 586215 (60592) 689829 (64033) <0.005
White matter mm3 465369 (44689) 521839 (23645) <0.02
CSF mm3 315480 (55098) 221033 (24736) <0.002
a Mann –Whitney U-test.
S.D. = standard deviation.
AN = anorexia nervosa.
CSF = cerebrospinal fluid.suggest that the degree of weight loss, indicated by
deltaBMI, and not the low body weight itself or a longer ill-
ness duration might be responsible for the development of
a brain pseudoatrophy. A remarkable weight loss might de-
termine a failure in metabolic compensatory mechanisms
contributing to cerebral volume alterations. Furthermore a
significant correlation was also observed between CSF vo-
lume and DeltaBMI/disease duration which could suggest
not only the importance of the impact of the weight loss
degree but also of the timetable in which this occurs.
Girls with AN displayed significant reduced GM and
WM volumes and increased CSF volumes, confirming
data from the literature [6]. Differently, girls with AN with
a higher BMI than that of our sample showed decreased
GM and widened CSF volume, without the alteration of
WM volumes [10]. In adult patients with AN, a widening
of cerebral sulci, enlarged lateral and third ventricle and a
decrease of the WM volume were described [8]. These
changes were attributed to lipolysis of the lipids that form
the bulk of myelin in both white and gray matter and the
reduced levels of IGF-1 have been considered responsible
for it. Moreover, the reduction of the brain tissue mass
would especially interest the white matter due to its
greater proportion of myelin [8].
Our study results outline the importance of an early
diagnosis of the illness in order to limit also cerebral
alterations. In fact, a precocious intervention and screening
programs might be necessary in order to prevent major
cerebral alterations of GM, WM and CSF. Concerning this
problem, our sample of anorexic adolescents get the first
access to our specialized unit with a mean disease duration
of more than one year. More awareness is needed among
pediatricians and neuropsychiatrists so that adolescents
at risk can be promptly recommended a consult with a
specialist. The main limitation of the present work was
sample size that should be increased in future studies.
However, our sample is comparable with other published
studies on adolescents with AN. Furthermore our intent
was to investigate a group of patients homogeneous for
age, type of anorexia and illness severity (all patients had a
BMI under 14).
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Anorexia nervosa is a psychiatric illness with a high
prevalence and origin in adolescence.
In adolescents with AN, the speed and magnitude of
weight loss, and not only BMI, represent a possible indica-
tor of disease severity. If confirmed by other studies, our
results could provide additional support concerning the
benefits of paediatricians’ and neuropsichiatrists’ increased
awareness, early detection and treatment of patients with
anorexia nervosa.
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